Global Hantavirus Metrics Reaffirm Stability as WHO Refines Differential Diagnosis Protocols

International health agencies have confirmed that the epidemiological curve for the recent Andes virus outbreak remains completely flat, with the global tally holding steady at 11 total cases (9 laboratory-confirmed, 2 probable) and 3 fatalities for several consecutive days. With all high-risk cohorts strictly isolated across 12 monitored nations, public health efforts are shifting toward laboratory quality control. The World Health Organization (WHO) released a clinical advisory focusing on strict differential diagnosis frameworks. Because distinct hantaviruses—such as the Puumala or Dobrava strains in Europe, and Sin Nombre in North America—circulate endemically and cause varying clinical syndromes, the WHO emphasizes utilizing virus-specific genetic sequencing. This protocol ensures that any random, unrelated hantavirus infection occurring globally is not misclassified as part of the MV Hondius travel cluster. The European Centre for Disease Prevention and Control (ECDC) reiterated that the broader community transmission risk for the Andes strain remains "Very Low" due to the successful containment of the primary cohort.